New Treatments For Prostate Cancer

PROSTATE CANCER – NEW TREATMENT BY RADIOTHERAPY
Research is continuing to try and improve technology and techniques to allow radiotherapy to the prostate gland to be more effective and to have fewer side effects. One way is to reduce the amount of radiation received by normal organs (bladder, bowel etc) and this has been improving over the last few years with better machines and techniques such as “conformal radiotherapy” and “IMRT”.
Work is also being carried out on combining brachytherapy with external therapy to allow some of the benefits of brachytherapy (fewer side effects, higher overall dose to the prostate cancer) to be used for men with more advanced prostate cancer without compromising the chance of cure.
NEW HORMONE THERAPY FOR PROSTATE CANCER
Some newer prostate cancer hormone treatments have fewer side effects than older hormone based drugs. Some are also felt to be more effective. All the time researchers are testing to try and find the best hormone tablets or injections for use in prostate cancer.
Other research is going on to try and work out the best time to give hormone treatment in prostate cancer and whether it is best to combine this treatment with other types of treatments such as chemotherapy or radiotherapy. Trials are currently being run to answer these questions and the results should be available in the next few years.
IMPROVEMENTS IN CHEMOTHERAPY TREATMENT FOR PROSTATE CANCER
In the past prostate cancer did not respond very well to chemotherapy drugs. However now there are newer drugs which are more powerful against prostate cancer and these have started to be used with more frequency in late prostate cancer which has already spread to other organs and which has become resistant to hormone treatments. The best drug found so far is Docetaxel, a new type of chemotherapy drug. It has several side effects including hair loss, nausea and risk of infection. Doctors are now looking to see if Docetaxel would work even better as a combination with other drugs.
USE OF BISPHOSPHONATE DRUGS FOR PROSTATE CANCER TREATMENT
These are a group of drugs which are most often used in treating osteoporosis. It has been recently found that they can also help reduce pain associated with cancer deposits or secondaries in the bones. They may also help reduce the risk of these abnormal bones from breaking or fracturing, by slowing down the damage caused to the bone by the cancer.
Research is ongoing to look at which of these drugs is the best for treating prostate cancer with bone disease and when the best time to start treatment with these drugs is.
ALTERNATIVE TO SURGERY FOR TREATMENT OF EARLY PROSTATE CANCER
There are 2 new treatments which are being researched as an alternative to surgery for some men with localised prostate cancer. Both options would not require a general anaesthetic (you would not need to be put to sleep) making them lower risk. Both treatments also have fewer side effects than radical surgery (”prostatectomy”). However neither has been in use long enough to know if it will prevent prostate cancer from coming back as effectively as standard treatments (surgery and radiotherapy).
Cryotherapy is the killing of cancer cells by freezing them. Needles are inserted into the prostate gland under local anaesthetic and liquid nitrogen is passed along them to freeze the prostate and the cancer cells within it. Currently it is being used for men whose prostate cancer has come back despite a first more conventional treatment and so is only being trialled for use as a first treatment option.
HIFU stands for high frequency ultrasound. Here ultrasound waves are directed to where there are cancer cells and are these are used to heat them up, thus killing them. In prostate cancer the ultrasound probe would be put into the back passage and from here ultrasound waves would be fired towards the prostate gland. The results so far have been good in that the treatment is safe and effective.
NEW TREATMENTS FOR PROSTATE CANCER IN VERY EARLY STAGES OF DEVELOPMENT
There are a number of alternative treatments which are still at a highly experimental stage of development. Gene therapy aims to replace the faulty genes in cancer cells with good ones which would allow the cell to self destruct if it felt it had become too mutated. (Cancer cells have lost this self destruct ability and continue to grow and divide despite having many abnormalities which would normally force the cell to die.) Vaccine treatment looks at ways of making the bodies own immune system recognise and kill cancerous sells. Endothelin blockers are a new type of drug treatment which works by preventing the prostate cancer cells to grow.
Many people may have heard that Vitamin D is being used in the treatment of prostate cancer however this therapy is in the very early experimental stages and is no where near being used in clinics as a cancer treatment. Vitamin D has been reported to block receptors on prostate cancer cells thereby slowing the rate of their growth but there is NO clinical evidence that this is in fact the case. Some researchers claim that the active form of Vitamin D slows the growth of prostate cancer but as yet this has only been tested on mice and other small animals.
Beta-sitosterol is a herbal remedy that people have started to associate with prostate cancer treatment. This natural plant fat has apparently been proven effective for the treatment of an enlarged prostate but not necessarily prostate cancer. According to research Beta-sitosterol MAY help to prevent the emergence of prostate cancer but this has not been clinically proven yet.

Carcinogenesis and Cancer

Carcinogenesis is the creation of a cancer.

Cancer is, ultimately, a disease of genes. Typically, a series of several mutations is required before a cell becomes a cancer cell. We distinguish between oncogenes, which promote cancer when “switched on” by a mutation, and tumor suppressor genes, which prevent cancer unless “switched off” by a mutation. These mutations can have various causes: radiation or chemicals called carcinogens; some inherited predisposition is not uncommon; some viruses that can cause cancer have also been described. Usually, they carry in their genome some oncogene or tumor suppressor inactivating gene. In about 15% of all cancers, viruses seem to play a role. Finally, damage by free radicals, which are a natural by-product of oxygen metabolism, can cause mutations in the DNA.

For most of the cancers, it cannot be told which event was the initial cause. However, with molecular biology, it is possible to characterize the mutations within a tumor, and to a certain extent to predict its behavior. For example, about half of the tumors are deficient in the tumor suppressor gene p53, also known as “the guardian of the genome”. This is associated with poor prospects for the patient, since those tumor cells are unlikely to go into apoptosis (programmed cell death) after they are damaged by therapy. There are more mutations that make a tumor more malignant. Telomerase mutations enable a tumor cell to divide indefinitely. Other mutations enable the tumor to grow new blood vessels to feed it, or to detach from the surrounding tissue, spreading to other parts of the body.

Malignant tumors such as carcinoma or sarcoma, lymphoma or leukemia originate from a cell or a group of cells in a multicellular organism that have several distinct properties:

increased cell division rate

not controllable by growth factors anymore

altered differentiation (specialization) ability

no ability for contact inhibition

ability to invade neighbouring tissue

ability to build metastases

ability to promote blood vessel growth

A cell that degenerates into a tumor cell does usually not acquire all these properties at once, but its daughter cells are selected to build them. This process is called cellular evolution. A first step in the development of a tumor cell is usually a small change in the DNA, often a point mutation, which leads, among other things, to a genetic instability of the cell. The instability increases to a point where the cell loses whole chromosomes, or has double ones. Also, the DNA methylation pattern of the cell changes, activating and deactivating genes more or less at random. Cells that divide at a high rate, such as stem cells, show a higher risk of becoming tumor cells than those which divide less or not at all, for example, neurons. If the initial tumor cell (or group of tumor cells) is not removed by the immune system, it will develop into cancer.

In cellular model systems, cells are exposed to carcinogenic influences (chemicals, radiation). In these systems, the first signs of a cell developing into a tumor cell are :

Immortality. The usual number of cell divisions for a mammalian cell is 50-60 (cell senescence), then it ceases to divide. Tumor cells keep dividing forever.

Altered morphology.

Building of cellular clusters (Foci).

Loss of contact inhibition.

Low or no need for growth factors.

Metastasis

Cancers are capable of spreading through the body by two mechanisms: local invasion and distant metastasis. Invasion refers to the direct migration and penetration by cancer cells into neighboring tissues. Metastasis refers to the ability of cancer cells to penetrate into lymphatic and blood vessels, circulate through the bloodstream, and then invade normal tissues elsewhere in the body. Cancer is most deadly when it metastasizes.

Forms of cancer

The term cancer is very broad and covers many different illnesses including:

Bladder cancer

Bone cancer

Brain tumor

Breast cancer

Cervical cancer

Colorectal cancer (includes colon, rectum, anus, and appendix)

Cancer of the esophagus

Hodgkin’s disease

Kidney cancer

Cancer of the larynx

Leukemia

Liver cancer

Lung cancer

Lymphoma

Melanoma

Moles and dysplastic nevi

Multiple myeloma

Muscular Cancer

Non-Hodgkin’s lymphoma

Oral cancer

Ovarian cancer

Cancer of the pancreas

Prostate cancer

Skin cancer

Stomach cancer

Testicular cancer

Teratoma

Thyroid cancer

Cancer of the uterus

Clinical aspects

The field of medicine concerned with the treatment of cancer is oncology.

Cancer has become an important problem with the rise in life expectancy, as the above mentioned mutations become more likely the longer a person lives. Though great progress in treatment has been made, most cancers in advanced stages remain incurable and ultimately fatal.

Treatment of cancer typically involves surgery to remove tumors and nearby lymph nodes to which the cancer may have spread, combined with radiation therapy and/or chemotherapy. The latter two target cells in the body that are rapidly dividing. This includes the cancer cells but also certain healthy ones, which is the reason for the severe side effects of these treatments.

Next Page »